# JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization

> **NCT05409118** · NA · WITHDRAWN · sponsor: **Endologix**

## Conditions studied

- AAA
- AAA - Abdominal Aortic Aneurysm

## Interventions

- **DEVICE:** Alto Abdominal Stent Graft System
- **DEVICE:** FDA Approved EVAR AAA Graft Systems

## Key facts

- **NCT ID:** NCT05409118
- **Lead sponsor:** Endologix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This is an EU protocol, and as a company, it was decided to only enroll within the US so this protocol/study is being withdrawn.
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05409118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05409118, "JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05409118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*